Great progress has been made on breast cancer in recent decades. Five-year survival rates in Australia are up to 91%, while 83% survive beyond 10 years. Yet the disease still claims thousands annually; and treatment often leaves those who do survive with significantly impaired quality of life. Our researchers, however, may just have the answer.
An international research team has discovered a key factor in the spread of prostate cancer.
PhD student Hannah Wardill may have uncovered the secret to making chemotherapy significantly less uncomfortable for cancer patients
Deb’s research focuses on the treatment of patients with chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL).